Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Twist Bioscience Corporation - Common Stock (NQ:TWST)

67.72 +0.85 (+1.27%)
Streaming Delayed Price Updated: 3:39 PM EDT, Jun 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Twist Bioscience Corporation - Common Stock

News headline image
Boehringer Ingelheim and Twist Bioscience Enter Therapeutic Antibody Discovery Collaboration
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience to Present at Baird 2021 Global Healthcare Conference
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience, SomaLogic Team Up For Antibodies, Target Discovery ↗
Twist Bioscience Corporation (NASDAQ: TWST) and SomaLogic announced a partnership to discover novel therapeutic targets and antibodies. Financial and other... 
Via Benzinga
News headline image
Twist Bioscience to Present at UBS Genomics 2.0 and Medtech Innovations Summit
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Corporation (TWST) Q3 2021 Earnings Call Transcript ↗
TWST earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
Twist Bioscience Stock Falls On Wider Q3 Loss, Sales Beat Estimates; Raises FY21 Guidance ↗
Twist Bioscience Corporation (NASDAQ: TWST) reported a 65% Y/Y increase in its third-quarter revenues to $35 million, beating the Wall Street estimate of $32.27 million... 
Via Benzinga
Topics Earnings
News headline image
Twist Bioscience: Q3 Earnings Insights ↗
Shares of Twist Bioscience (NASDAQ:TWST) remained unaffected after the company reported Q3 results. Quarterly Results Earnings per share were down 22.39% year over year to... 
Via Benzinga
News headline image
Twist Bioscience Reports Third Quarter Fiscal 2021 Financial Results
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Appoints Drug Discovery Leader Melissa Starovasnik, Ph.D., to Board of Directors
From Twist Bioscience Corporation
Via Business Wire
News headline image
The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)... 
Via Benzinga
News headline image
Earnings Scheduled For August 6, 2021 ↗
Companies Reporting Before The Bell • Liberty Braves Group (NASDAQ:BATRA) is projected to report quarterly loss at $0.03 per share on revenue of $154.00 million.... 
Via Benzinga
News headline image
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs ↗
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results.... 
Via Benzinga
News headline image
Twist Bioscience Incorporates MOLCURE AI Technology to Augment Therapeutic Antibody Discovery
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Now Shipping Synthetic RNA Positive Controls for Delta (B.1.617.2) SARS-CoV-2 Variant for Development of Accurate Diagnostic Tests
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience to Report Fiscal 2021 Third Quarter Financial Results on Friday, August 6, 2021
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Acquires NGS Library Preparation Maker iGenomX
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Collaborates with Regeneron for Production of Genotyping by Sequencing Panel to Enable Diverse Genome-wide Screening
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Announces Fireside Chat and Presentation at BIO Digital
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Stock Hits 80-Plus Relative Strength Rating Benchmark ↗
TwistBioscienceCorp shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 79 to 82. 
Via Investor's Business Daily
News headline image
DNA Data Storage Alliance Publishes First White Paper, Launches Website
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Begins Shipping of Synthetic RNA Controls for Kappa (B.1.617.1) SARS-CoV-2 Variants for Development of Accurate Tests
From Twist Bioscience Corporation
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For June 4, 2021 ↗
Upgrades According to Argus Research, the prior rating for Diageo PLC (NYSE:DEO) was changed from Hold to Buy. The current stock performance of Diageo shows a 52-week-high... 
Via Benzinga
News headline image
2 Top Biotech Picks to Buy and Hold for the Next 10 Years ↗
Incredible scientific advances could reward investors -- if they have the patience. 
Via The Motley Fool
News headline image
Twist Bioscience Stock Scores Relative Strength Rating Upgrade ↗
When adding stocks to your watch list, look for stocks with an 80 or higher RS Rating. Twist Bioscience just met that criteria with a new score of 84. 
Via Investor's Business Daily
News headline image
Twist Bioscience Launches Enzymatic Fragmentation Library Preparation Kit for High Uniformity, High-Yield Amplification, Streamlined Next Generation Sequencing Workflow for Targeted Applications
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience to Present at Upcoming Virtual Conferences
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Supports the Engineering Biology Research Consortium as it Publishes Statement of Ethics
From Twist Bioscience Corporation
Via Business Wire
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
Gainers Protagenic Therapeutics (NASDAQ:PTIX) shares increased by 84.03% to $3.92 during Monday's regular session. Trading volume for this security as of 12:30 EST is... 
Via Benzinga
News headline image
64 Biggest Movers From Yesterday ↗
Gainers InnSuites Hospitality Trust (NYSE: IHT) shares jumped 82.6% to settle at $6.39 on Monday. Protagenic Therapeutics, Inc. (NASDAQ: PTIX) shares surged 53.5% to close at $3.... 
Via Benzinga
News headline image
Barron's Picks And Pans: Hannon Armstrong, Seagate, Tesla, Virtu Financial And More ↗
This weekend's Barron's cover story helps investors to prepare for the changes ahead. Other featured articles discuss how to invest in tomorrow's big tech trends,... 
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.